Close

Ratings by Wedbush (Laura Chico)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/10/2024 Longboard Pharmaceuticals Inc LBPH Maintain Outperform
(N/A)
 
 
  Details
5/31/2024 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
5/14/2024 Voyager Therapeutics VYGR Maintain Neutral
(N/A)
 
 
  Details
5/10/2024 Xenon Pharmaceuticals XENE Maintain Outperform
(N/A)
 
 
  Details
5/10/2024 Dianthus Therapeutics DNTH Maintain Outperform
(N/A)
 
 
  Details
5/9/2024 Pharvaris B.V. PHVS Maintain Outperform
(N/A)
 
 
  Details
5/8/2024 Denali Therapeutics Inc. DNLI Maintain Outperform
(N/A)
 
 
  Details
5/3/2024 Longboard Pharmaceuticals Inc LBPH Maintain Outperform
(N/A)
 
 
  Details
4/24/2024 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
4/11/2024 Rallybio Corp. RLYB Maintain Outperform
(N/A)
 
 
  Details
4/8/2024 Praxis Precision Medicines Inc. PRAX Maintain Neutral
(N/A)
 
 
  Details
4/5/2024 Ovid Therapeutics Inc OVID New Coverage Outperform
(N/A)
3.05
(3.20)
4.92% Details
3/26/2024 Astria Therapeutics ATXS Maintain Outperform
(N/A)
 
 
  Details
3/26/2024 Stoke Therapeutics STOK Maintain Outperform
(N/A)
 
 
  Details
3/22/2024 Dianthus Therapeutics DNTH Maintain Outperform
(N/A)
 
 
  Details
3/21/2024 Vera Therapeutics VERA Maintain Outperform
(N/A)
 
 
  Details
3/5/2024 Praxis Precision Medicines Inc. PRAX Maintain Neutral
(N/A)
 
 
  Details
3/1/2024 Xenon Pharmaceuticals XENE Maintain Outperform
(N/A)
 
 
  Details
2/28/2024 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
2/16/2024 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
2/7/2024 Rallybio Corp. RLYB Maintain Outperform
(N/A)
 
 
  Details
1/29/2024 Travere Therapeutics TVTX Maintain Outperform
(N/A)
 
 
  Details
1/29/2024 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
1/29/2024 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
1/29/2024 Neurocrine Bio. NBIX Maintain Outperform
(N/A)
 
 
  Details
1/22/2024 Viridian Therapeutic VRDN Maintain Outperform
(N/A)
 
 
  Details
1/12/2024 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
1/12/2024 Ardelyx, Inc ARDX Maintain Outperform
(N/A)
 
 
  Details
1/8/2024 Longboard Pharmaceuticals Inc LBPH Maintain Outperform
(N/A)
 
 
  Details
12/22/2023 Karuna Therapeutics Inc. KRTX Downgrade Neutral
(Outperform)
215.19
(329.83)
53.27% Details
11/29/2023 Praxis Precision Medicines Inc. PRAX Maintain Neutral
(N/A)
 
 
  Details
11/22/2023 Dianthus Therapeutics DNTH New Coverage Outperform
(N/A)
11.50
(26.96)
134.43% Details
11/14/2023 Design Therapeutics Inc DSGN Maintain Neutral
(N/A)
 
 
  Details
11/10/2023 Edgewise Therapeutics EWTX Maintain Outperform
(N/A)
 
 
  Details
11/10/2023 Rallybio Corp. RLYB Maintain Outperform
(N/A)
 
 
  Details
11/9/2023 Xenon Pharmaceuticals XENE Maintain Outperform
(N/A)
 
 
  Details
11/8/2023 PepGen Inc. PEPG Maintain Outperform
(N/A)
 
 
  Details
10/26/2023 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
10/13/2023 Astria Therapeutics ATXS Maintain Outperform
(N/A)
 
 
  Details
9/25/2023 Pharvaris B.V. PHVS New Coverage Outperform
(N/A)
20.32
(18.10)
-10.93% Details
9/13/2023 Neurocrine Bio. NBIX Maintain Outperform
(N/A)
 
 
  Details
8/11/2023 Vera Therapeutics VERA Maintain Neutral
(N/A)
 
 
  Details
8/9/2023 Denali Therapeutics Inc. DNLI Maintain Outperform
(N/A)
 
 
  Details
8/8/2023 Astria Therapeutics ATXS Maintain Outperform
(N/A)
 
 
  Details
8/8/2023 Chinook Therapeutics KDNY Downgrade Neutral
(Outperform)
40.35
(40.39)
0.1% Details
8/7/2023 Sage Therapeutics SAGE Downgrade Neutral
(N/A)
36.10
(11.50)
-68.14% Details
8/7/2023 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
7/31/2023 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
7/26/2023 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
7/20/2023 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
5/10/2023 Xenon Pharmaceuticals XENE Maintain Outperform
(N/A)
 
 
  Details
4/10/2023 Rallybio Corp. RLYB New Coverage Outperform
(N/A)
4.91
(1.66)
-66.19% Details
3/3/2023 Ardelyx, Inc ARDX Upgrade Outperform
(Neutral)
2.89
(6.49)
124.57% Details
2/21/2023 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
2/21/2023 Travere Therapeutics TVTX Upgrade Outperform
(Neutral)
17.82
(7.24)
-59.37% Details
2/17/2023 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
2/6/2023 Neurocrine Bio. NBIX Maintain Outperform
(N/A)
 
 
  Details
1/4/2023 Vera Therapeutics VERA Downgrade Neutral
(Outperform)
18.30
(37.40)
104.37% Details
11/15/2022 Impel Neuropharma IMPL Downgrade Neutral
(Outperform)
3.36
(0.24)
-92.86% Details
11/9/2022 Xenon Pharmaceuticals XENE Maintain Outperform
(N/A)
 
 
  Details
11/8/2022 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
11/3/2022 Edgewise Therapeutics EWTX Maintain Outperform
(N/A)
 
 
  Details
9/28/2022 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
9/16/2022 Vigil Neuroscience Inc VIGL New Coverage Outperform
(N/A)
9.00
(4.37)
-51.44% Details
9/12/2022 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
8/18/2022 Viridian Therapeutic VRDN Maintain Outperform
(N/A)
 
 
  Details
8/15/2022 Impel Neuropharma IMPL Maintain Outperform
(N/A)
 
 
  Details
8/10/2022 Karuna Therapeutics Inc. KRTX Maintain Outperform
(N/A)
 
 
  Details
8/10/2022 Xenon Pharmaceuticals XENE Maintain Outperform
(N/A)
 
 
  Details
8/8/2022 Biohaven Pharmaceutical Holding BHVN Downgrade Neutral
(Outperform)
146.98
(33.41)
-77.27% Details
7/14/2022 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
6/27/2022 Xenon Pharmaceuticals XENE Maintain Outperform
(N/A)
 
 
  Details
6/6/2022 Praxis Precision Medicines Inc. PRAX Downgrade Neutral
(Outperform)
8.59
(40.05)
366.24% Details
5/31/2022 PepGen Inc. PEPG New Coverage Outperform
(N/A)
10.88
(17.48)
60.66% Details
5/23/2022 Chinook Therapeutics KDNY Maintain Outperform
(N/A)
 
 
  Details
5/13/2022 Chinook Therapeutics KDNY Maintain Outperform
(N/A)
 
 
  Details
5/3/2022 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
4/19/2022 Vera Therapeutics VERA New Coverage Outperform
(N/A)
23.12
(37.40)
61.76% Details
3/31/2022 Taysha Gene Therapies TSHA Maintain Outperform
(N/A)
 
 
  Details
3/24/2022 Aptinyx APTX Maintain Outperform
(N/A)
 
 
  Details
3/8/2022 Voyager Therapeutics VYGR Maintain Neutral
(N/A)
 
 
  Details
3/1/2022 Denali Therapeutics Inc. DNLI Maintain Outperform
(N/A)
 
 
  Details
3/1/2022 Ardelyx, Inc ARDX Maintain Neutral
(N/A)
 
 
  Details
2/28/2022 Praxis Precision Medicines Inc. PRAX Maintain Outperform
(N/A)
 
 
  Details
2/14/2022 Longboard Pharmaceuticals Inc LBPH New Coverage Outperform
(N/A)
4.50
(19.95)
343.33% Details
1/24/2022 Karuna Therapeutics Inc. KRTX Maintain Outperform
(N/A)
 
 
  Details
1/12/2022 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
11/30/2021 Ardelyx, Inc ARDX Maintain Neutral
(N/A)
 
 
  Details
11/12/2021 Chinook Therapeutics KDNY Maintain Outperform
(N/A)
 
 
  Details
11/11/2021 Xenon Pharmaceuticals XENE Maintain Outperform
(N/A)
 
 
  Details
11/10/2021 Taysha Gene Therapies TSHA Maintain Outperform
(N/A)
 
 
  Details
11/10/2021 Astria Therapeutics ATXS Maintain Outperform
(N/A)
 
 
  Details
11/9/2021 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(N/A)
 
 
  Details
11/9/2021 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
11/8/2021 Chinook Therapeutics KDNY Maintain Outperform
(N/A)
 
 
  Details
11/8/2021 Stoke Therapeutics STOK Maintain Outperform
(N/A)
 
 
  Details
11/4/2021 Karuna Therapeutics Inc. KRTX Maintain Outperform
(N/A)
 
 
  Details
11/4/2021 Passage Bio Inc. PASG Maintain Outperform
(N/A)
 
 
  Details
11/3/2021 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
10/20/2021 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
10/13/2021 Ardelyx, Inc ARDX Maintain Neutral
(N/A)
 
 
  Details
10/4/2021 Xenon Pharmaceuticals XENE Maintain Outperform
(N/A)
 
 
  Details
9/28/2021 Viridian Therapeutic VRDN Maintain Outperform
(N/A)
 
 
  Details
9/10/2021 Apellis Pharmaceuticals APLS Downgrade Neutral
(Outperform)
55.61
(42.56)
-23.47% Details
9/3/2021 Impel Neuropharma IMPL Maintain Outperform
(N/A)
 
 
  Details
9/2/2021 Catabasis CATB New Coverage Outperform
(N/A)
9.41
(8.54)
-9.25% Details
8/19/2021 Apellis Pharmaceuticals APLS Upgrade Outperform
(Neutral)
59.02
(55.61)
-5.78% Details
8/16/2021 Praxis Precision Medicines Inc. PRAX Maintain Outperform
(N/A)
 
 
  Details
8/16/2021 Taysha Gene Therapies TSHA Maintain Outperform
(N/A)
 
 
  Details
8/13/2021 Ardelyx, Inc ARDX Maintain Neutral
(N/A)
 
 
  Details
8/5/2021 Passage Bio Inc. PASG Maintain Outperform
(N/A)
 
 
  Details
8/4/2021 Neurocrine Bio. NBIX Maintain Outperform
(N/A)
 
 
  Details
8/3/2021 Sage Therapeutics SAGE Maintain Outperform
(N/A)
 
 
  Details
8/3/2021 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
7/22/2021 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
7/20/2021 Ardelyx, Inc ARDX Downgrade Neutral
(Outperform)
7.70
(6.49)
-15.71% Details
6/9/2021 Taysha Gene Therapies TSHA Maintain Outperform
(N/A)
 
 
  Details
6/8/2021 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
6/7/2021 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
5/26/2021 Travere Therapeutics TVTX Downgrade Neutral
(Outperform)
17.75
(7.24)
-59.21% Details
5/24/2021 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
5/18/2021 Impel Neuropharma IMPL New Coverage Outperform
(N/A)
13.89
(0.24)
-98.27% Details
5/13/2021 Chinook Therapeutics KDNY Maintain Outperform
(N/A)
 
 
  Details
5/10/2021 Stoke Therapeutics STOK Upgrade Outperform
(Neutral)
32.46
(17.52)
-46.03% Details
5/6/2021 Neurocrine Bio. NBIX Maintain Outperform
(N/A)
 
 
  Details
5/5/2021 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
5/4/2021 Sage Therapeutics SAGE Maintain Outperform
(N/A)
 
 
  Details
5/3/2021 Denali Therapeutics Inc. DNLI Maintain Outperform
(N/A)
 
 
  Details
4/22/2021 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
4/20/2021 Edgewise Therapeutics EWTX New Coverage Outperform
(N/A)
26.76
(17.91)
-33.07% Details
3/25/2021 Aptinyx APTX Maintain Outperform
(N/A)
 
 
  Details
3/23/2021 Ardelyx, Inc ARDX New Coverage Outperform
(N/A)
6.96
(6.49)
-6.75% Details
3/17/2021 Praxis Precision Medicines Inc. PRAX Maintain Outperform
(N/A)
 
 
  Details
3/1/2021 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(N/A)
 
 
  Details
2/10/2021 Stoke Therapeutics STOK Downgrade Neutral
(Outperform)
66.33
(17.52)
-73.59% Details
2/8/2021 Viela Bio VIE Downgrade Neutral
(Outperform)
52.85
(53.01)
0.3% Details
2/5/2021 Neurocrine Bio. NBIX Maintain Outperform
(N/A)
 
 
  Details
2/3/2021 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
2/3/2021 Voyager Therapeutics VYGR Downgrade Neutral
(Outperform)
8.00
(8.80)
10% Details
2/2/2021 Travere Therapeutics TVTX Maintain Outperform
(N/A)
 
 
  Details
1/29/2021 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
1/29/2021 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
1/29/2021 Neurocrine Bio. NBIX Maintain Outperform
(N/A)
 
 
  Details
1/29/2021 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(N/A)
 
 
  Details
1/25/2021 Passage Bio Inc. PASG New Coverage Outperform
(N/A)
19.81
(1.07)
-94.6% Details
1/13/2021 Acorda Therapeutics, Inc. ACOR Maintain Neutral
(N/A)
 
 
  Details
1/6/2021 Chinook Therapeutics KDNY New Coverage Outperform
(N/A)
15.52
(40.39)
160.24% Details
12/23/2020 Prevail Therapeutics PRVL Downgrade Neutral
(Outperform)
23.15
(23.00)
-0.65% Details
12/14/2020 Alexion Pharmaceuticals ALXN Downgrade Neutral
(Outperform)
118.87
(182.01)
53.12% Details
12/7/2020 Ultragenyx Pharma RARE Downgrade Neutral
(Outperform)
128.53
(43.12)
-66.45% Details
12/1/2020 Praxis Precision Medicines Inc. PRAX Maintain Outperform
(N/A)
 
 
  Details
11/16/2020 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
11/11/2020 Viela Bio VIE Maintain Outperform
(N/A)
 
 
  Details
11/10/2020 Denali Therapeutics Inc. DNLI Maintain Outperform
(N/A)
 
 
  Details
11/10/2020 Voyager Therapeutics VYGR Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 Denali Therapeutics Inc. DNLI Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 Retrophin RTRX Maintain Outperform
(N/A)
 
 
  Details
11/5/2020 Karuna Therapeutics Inc. KRTX Maintain Outperform
(N/A)
 
 
  Details
11/2/2020 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
10/29/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
10/28/2020 Ultragenyx Pharma RARE Maintain Outperform
(N/A)
 
 
  Details
10/13/2020 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(N/A)
 
 
  Details
10/7/2020 Stoke Therapeutics STOK Maintain Outperform
(N/A)
 
 
  Details
10/7/2020 Karuna Therapeutics Inc. KRTX Maintain Outperform
(N/A)
 
 
  Details
9/18/2020 Retrophin RTRX New Coverage Outperform
(N/A)
19.90
(24.25)
21.86% Details
9/11/2020 Sage Therapeutics SAGE Upgrade Outperform
(Neutral)
54.25
(11.50)
-78.8% Details
8/13/2020 Viela Bio VIE Maintain Outperform
(N/A)
 
 
  Details
8/10/2020 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
8/10/2020 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(N/A)
 
 
  Details
8/7/2020 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(N/A)
 
 
  Details
8/6/2020 Denali Therapeutics Inc. DNLI Maintain Outperform
(N/A)
 
 
  Details
8/5/2020 Karuna Therapeutics Inc. KRTX Maintain Outperform
(N/A)
 
 
  Details
7/30/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
7/22/2020 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
7/1/2020 Ultragenyx Pharma RARE Maintain Outperform
(N/A)
 
 
  Details
6/9/2020 Neurocrine Bio. NBIX New Coverage Outperform
(N/A)
115.86
(136.26)
17.61% Details
6/2/2020 Karuna Therapeutics Inc. KRTX Maintain Outperform
(N/A)
 
 
  Details
5/26/2020 Prevail Therapeutics PRVL Maintain Outperform
(N/A)
 
 
  Details
5/22/2020 Xenon Pharmaceuticals XENE Maintain Outperform
(N/A)
 
 
  Details
5/15/2020 Aptinyx APTX Maintain Outperform
(N/A)
 
 
  Details
5/14/2020 Viela Bio VIE Maintain Outperform
(N/A)
 
 
  Details
5/8/2020 Sage Therapeutics SAGE Downgrade Neutral
(Outperform)
40.76
(11.50)
-71.79% Details
5/8/2020 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(N/A)
 
 
  Details
5/8/2020 Denali Therapeutics Inc. DNLI Maintain Outperform
(N/A)
 
 
  Details
5/7/2020 Ultragenyx Pharma RARE Maintain Outperform
(N/A)
 
 
  Details
5/6/2020 Voyager Therapeutics VYGR Maintain Outperform
(N/A)
 
 
  Details
4/30/2020 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
4/13/2020 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
4/13/2020 Ultragenyx Pharma RARE Maintain Outperform
(N/A)
 
 
  Details
4/13/2020 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(N/A)
 
 
  Details
4/13/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
4/8/2020 Sage Therapeutics SAGE Maintain Outperform
(N/A)
 
 
  Details
4/6/2020 Millendo Therapeutics Inc. MLND Downgrade Neutral
(Outperform)
4.85
(1.06)
-78.14% Details
3/26/2020 Prevail Therapeutics PRVL Maintain Outperform
(N/A)
 
 
  Details
3/25/2020 Xenon Pharmaceuticals XENE New Coverage Outperform
(N/A)
10.01
(38.04)
280.02% Details
3/24/2020 Karuna Therapeutics Inc. KRTX New Coverage Outperform
(N/A)
71.86
(329.83)
358.99% Details
3/13/2020 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(N/A)
 
 
  Details
3/11/2020 Millendo Therapeutics Inc. MLND Maintain Outperform
(N/A)
 
 
  Details
3/11/2020 Apellis Pharmaceuticals APLS Upgrade Neutral
(Underperform)
30.95
(42.56)
37.51% Details
3/4/2020 Logitech International VTGR Maintain Outperform
()
 
 
  Details
2/28/2020 Denali Therapeutics Inc. DNLI Upgrade Outperform
(N/A)
19.02
(22.12)
16.3% Details
1/30/2020 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
1/29/2020 Denali Therapeutics Inc. DNLI Maintain Neutral
(N/A)
 
 
  Details
1/29/2020 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(N/A)
 
 
  Details
12/18/2019 Stoke Therapeutics STOK New Coverage Outperform
(N/A)
24.98
(17.52)
-29.86% Details
12/5/2019 Sage Therapeutics SAGE Maintain Outperform
(N/A)
 
 
  Details
11/22/2019 Apellis Pharmaceuticals APLS New Coverage Underperform
(N/A)
28.70
(42.56)
48.29% Details
11/22/2019 Biohaven Pharmaceutical Holding BHVN New Coverage Outperform
(N/A)
52.70
(33.41)
-36.6% Details
10/23/2019 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
10/22/2019 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
10/16/2019 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
10/3/2019 Dova Pharmaceuticals Inc DOVA Downgrade Neutral
(Outperform)
28.23
(28.04)
-0.67% Details
9/26/2019 Denali Therapeutics Inc. DNLI New Coverage Neutral
(N/A)
17.44
(22.12)
26.83% Details
9/12/2019 Aptinyx APTX New Coverage Outperform
(N/A)
3.95
(0.06)
-98.48% Details
7/15/2019 Prevail Therapeutics PRVL New Coverage Outperform
(N/A)
12.13
(23.00)
89.61% Details
6/25/2019 Acer Therapeutics ACER Maintain Outperform
(N/A)
 
 
  Details
5/23/2019 Acer Therapeutics ACER New Coverage Outperform
(N/A)
19.71
(0.90)
-95.43% Details
5/23/2019 Biogen BIIB New Coverage Neutral
(N/A)
232.92
(233.84)
0.39% Details
5/23/2019 Acorda Therapeutics, Inc. ACOR New Coverage Neutral
(N/A)
10.93
(0.66)
-93.96% Details
5/23/2019 Dova Pharmaceuticals Inc DOVA New Coverage Outperform
(N/A)
10.42
(28.23)
170.92% Details
5/23/2019 Alexion Pharmaceuticals ALXN New Coverage Outperform
(N/A)
128.80
(182.01)
41.31% Details
5/23/2019 Sage Therapeutics SAGE New Coverage Outperform
(N/A)
171.03
(11.50)
-93.28% Details